NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 35573-0428-80 — Pantoprazole 40 mg delayed-release tabletAI (280 hospitals, 28,206–28,764 samples)
• NDC 59762-0531-02 — Phenytoin oral suspension 125 mg per 5 mLAI (200 hospitals, 28,206–28,764 samples)
• NDC 29300-0343-01 — BACLOFEN 10 MG TABLETAI (104 hospitals, 28,206–28,764 samples)
• NDC 60687-0417-71 — Hydrocodone-acetaminophen oral liquid, unit doseAI (405 hospitals, 28,087–28,762 samples)
• NDC 62559-0490-01 — Atropine and diphenoxylate tabletsAI (301 hospitals, 28,205–28,754 samples)
• NDC 00641-0376-21 — Diphenhydramine 50 mg/mL injectionAI (756 hospitals, 21,196–28,747 samples)
• NDC 00168-0007-30 — NYSTATIN 100,000 UNIT/GRAM TOPICAL OINTMENTAI (98 hospitals, 27,727–28,744 samples)
• NDC 81033-0025-51 — Lidocaine-prilocaine numbing creamAI (138 hospitals, 27,683–28,736 samples)
• NDC 44567-0641-01 — Norepinephrine IV infusion in salineAI (193 hospitals, 28,671–28,734 samples)
• NDC 00409-1283-04 — Hydromorphone injection syringe, 0.5 mgAI (187 hospitals, 26,018–28,727 samples)
• NDC 63323-0285-07 — Ropivacaine (preservative-free) 0.2% injectionAI (334 hospitals, 27,700–28,726 samples)
• NDC 00904-7027-61 — Oxybutynin chloride 5 mg tabletsAI (580 hospitals, 28,151–28,718 samples)
• NDC 72485-0104-01 — Caffeine citrate injection (intravenous solution)AI (450 hospitals, 28,522–28,711 samples)
• NDC 51079-0736-20 — Haloperidol 5 mg oral tabletsAI (513 hospitals, 28,013–28,706 samples)
• NDC 10572-0302-01 — Polyethylene glycol electrolyte oral solutionAI (246 hospitals, 28,082–28,703 samples)
• NDC 50742-0554-01 — Fentanyl 75 mcg/hr skin patchAI (81 hospitals, 27,738–28,692 samples)
• NDC 57664-0396-88 — VENLAFAXINE 100 MG TABLETAI (119 hospitals, 28,151–28,691 samples)
• NDC 16729-0471-63 — Glycopyrrolate injection 0.2 mg per mLAI (119 hospitals, 28,399–28,687 samples)
• NDC 66685-1002-02 — Amoxicillin-clavulanate 500/125 mg tabletAI (267 hospitals, 28,162–28,684 samples)
• NDC 43066-0023-01 — Ropivacaine (preservative-free) 0.5% injectionAI (271 hospitals, 27,769–28,678 samples)
• NDC 64980-0279-03 — Glipizide extended-release 2.5 mg tabletAI (289 hospitals, 28,029–28,677 samples)
• NDC 00990-7935-19 — Dextrose 20% intravenous sugar solutionAI (529 hospitals, 27,349–28,672 samples)
• NDC 65162-0898-03 — Aripiprazole 10 mg tabletAI (300 hospitals, 27,926–28,664 samples)
• NDC 42571-0162-42 — Amoxicillin-clavulanate 875/125 mg tabletAI (374 hospitals, 28,059–28,662 samples)
• NDC 65162-0914-46 — Tobramycin nebulizer solutionAI (435 hospitals, 28,625–28,661 samples)
• NDC 00941-0679-52 — Icodextrin peritoneal dialysis solution, 2000 mL bagAI (54 hospitals, 28,625–28,661 samples)
• NDC 00409-0001-25 — Midazolam injection, 2 mg per 2 mL vialAI (301 hospitals, 24,463–28,657 samples)
• NDC 00781-6157-46 — Amoxicillin 400 mg/5 mL oral suspensionAI (187 hospitals, 27,827–28,655 samples)
• NDC 69315-0117-01 — Furosemide 40 mg oral tabletsAI (344 hospitals, 28,058–28,652 samples)
• NDC 00409-1165-01 — Bupivacaine 0.75% injectable local anesthetic solutionAI (436 hospitals, 26,591–28,652 samples)
• NDC 00641-6080-01 — Ondansetron injection 4 mgAI (265 hospitals, 25,520–28,652 samples)
• NDC 13668-0095-90 — Pramipexole 1.5 mg tablets, 90-count bottleAI (242 hospitals, 28,147–28,651 samples)
• NDC 00409-9093-11 — Fentanyl injection 50 mcg/mL, 2 mL vialAI (75 hospitals, 14,145–28,644 samples)
• NDC 68084-0617-01 — ESCITALOPRAM 10 MG TABLETAI (462 hospitals, 27,626–28,643 samples)
• NDC 60687-0388-01 — Alprazolam 0.5 mg tabletsAI (399 hospitals, 27,671–28,643 samples)
• NDC 42858-0750-40 — Buprenorphine 5 mcg/hr weekly patchAI (279 hospitals, 27,908–28,637 samples)
• NDC 50268-0314-15 — Finasteride 5 mg tabletsAI (349 hospitals, 28,059–28,635 samples)
• NDC 00641-6059-10 — Midazolam 5 mg/5 mL injectionAI (537 hospitals, 24,594–28,626 samples)
• NDC 64980-0282-03 — mesalamine 1,000 mg rectal suppositoryAI (187 hospitals, 27,888–28,626 samples)
• NDC 00781-7133-58 — Estradiol weekly skin patch, 0.05 mgAI (108 hospitals, 27,888–28,626 samples)
• NDC 76045-0009-11 — Dilaudid 1 mg/mL injectionAI (600 hospitals, 24,043–28,624 samples)
• NDC 00004-0822-05 — Oseltamivir oral liquid medicineAI (558 hospitals, 27,773–28,619 samples)
• NDC 44567-0622-01 — Calcium gluconate in sodium chloride, 100 mL bagAI (218 hospitals, 28,558–28,612 samples)
• NDC 51079-0978-20 — Carbidopa and levodopa extended-release tablets 25-100 mgAI (563 hospitals, 28,018–28,612 samples)
• NDC 11980-0779-05 — Ofloxacin 0.3% eye drops, 5 mL bottleAI (303 hospitals, 27,419–28,607 samples)
• NDC 51862-0453-04 — Clonidine hydrochloride 0.1 mg patchAI (265 hospitals, 27,886–28,606 samples)
• NDC 00378-6998-89 — Sodium chloride 10% nebulizer solutionAI (282 hospitals, 27,611–28,601 samples)
• NDC 65862-0079-30 — Terbinafine 250 mg tabletsAI (445 hospitals, 27,962–28,601 samples)
• NDC 60687-0327-01 — Quetiapine 25 mg tablets, 100-count blister packAI (511 hospitals, 27,898–28,600 samples)
• NDC 00781-2613-01 — Amoxicillin 500 mg capsulesAI (629 hospitals, 27,632–28,595 samples)